Candriam S.C.A. Medtronic PLC Transaction History

Candriam S.C.A.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$87.4 - $113.09 $3,933 - $5,089	-45 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$100.58 - $112.38 $4,526 - $5,057	45 New	45 $5,000
Q4 2021 Feb 10, 2022	SELL	$99.53 - $127.75 $5,076 - $6,515	-51 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$122.75 - $135.17 $1,718 - $1,892	14 Added 37.84%	51 $6,000
Q2 2021 Jul 20, 2021	SELL	$118.19 - $131.5 $118 - $131	-1 Reduced 2.63%	37 $5,000
Q1 2021 Apr 29, 2021	BUY	$111.18 - $119.74 $111 - $119	1 Added 2.7%	38 $4,000
Q4 2020 Jan 22, 2021	SELL	$100.57 - $117.14 $703 - $819	-7 Reduced 15.91%	37 $4,000
Q3 2020 Oct 19, 2020	BUY	$90.13 - $108.78 $1,622 - $1,958	18 Added 69.23%	44 $5,000
Q2 2020 Jul 23, 2020	BUY	$84.11 - $103.33 $1,009 - $1,239	12 Added 85.71%	26 $2,000
Q1 2020 May 26, 2020	BUY	$72.92 - $121.3 $437 - $727	6 Added 75.0%	14 $1,000
Q3 2019 Oct 21, 2019	BUY	$98.02 - $111.18 $294 - $333	3 Added 60.0%	8 $1,000
Q2 2019 Aug 01, 2019	BUY	$84.15 - $99.38 $420 - $496	5 New	5 $487,000
Q1 2019 May 02, 2019	SELL	$82.45 - $93.79 $1,071 - $1,219	-13 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$85.8 - $99.49 $1,115 - $1,293	13 New	13 $1,000

2,282

1.02B

7.95M

5.37M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $114B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.